Zurueck zur Suche

Reporte zur Charge U026207

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

32Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
SC 7 NY 3 MI 3 WI 2 ME 2 IA 2 NJ 1 MD 1 MA 1 WA 1 IL 1 IN 1

VAERS 2214110

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

schwer
Staat
NJ
Alter
15,0
Geschlecht
M
Eingang
04.04.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Head injury Neurological examination Syncope

Symptomtext

A few minutes after receiving vaccines, approx 8:10pm, the pt fainted and fell in the exam room. The fall was witnessed by the pt's aunt. Per pt's aunt, the pt "got up from the table, fainted, fell and hit his head on the floor." When the nurse arrived to the room, the pt was laying on the floor with the aunt rubbing his head. Pt opened his eyes. The doctor was immediately called to the room and vital signs were taken. Pt denied pain and dizziness. Pt slowly got up from the floor and was able to sit on the table. Pt denied nausea, dizziness, and pain. The doctor assessed the pt and completed a neuro exam. The doctor advised the aunt to take the pt to the ER if pt c/o h/a, n/v, blurry vision. Pt stayed in waiting area for observation before leaving. Upon leaving, pt states he is feeling better. He continues to deny pain, dizziness, and nausea.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported.
Vorgeschichte
None reported.
Andere Medikamente
NA
Allergien
No known allergies.
Vorherige Impfungen
-

VAERS 2424071

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

mild
Staat
WI
Alter
1,3
Geschlecht
F
Eingang
30.08.2022
Impfdatum
15.08.2022
Beginn
26.08.2022
Tage bis Beginn
11,0
Dosis
UNK
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site induration

Symptomtext

1 x 2 cm reddened area on her left lateral thigh. There is palpable induration. Parents use Benadryl and hydrocortisone to site. Areas still has redness and palpable induration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
No tests or labs. Evaluated by Dr.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2348500

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

mild
Staat
MD
Alter
1,0
Geschlecht
M
Eingang
01.07.2022
Impfdatum
28.06.2022
Beginn
29.06.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Urticaria

Symptomtext

mild urticarial rash noted face, trunk , extremities note the following day after vaccination. As of 7/1, rash comes and goes and disappears with Diphenhydramine. Child acting fine, no fever, eating, drinking and playing as normal

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Otitis media diagnosed 6/17/22, treated with Amoxicillin x 10 days. COVID vaccine given in combination with other 12 month vaccines: MMR, Varivax and Hepatitis A
Vorgeschichte
none
Andere Medikamente
Amoxicillin started on 6/17 for ear infection - completed course day prior to vaccine
Allergien
None known
Vorherige Impfungen
-

VAERS 2269063

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

mild
Staat
NY
Alter
1,1
Geschlecht
M
Eingang
10.05.2022
Impfdatum
25.04.2022
Beginn
09.05.2022
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pallor Rash Rash maculo-papular Skin lesion

Symptomtext

Pt presented on 5/9/22 with rash to torso, face, trunk, plantar surface. Started on 5/9/22 am, on trunk that spread. Not painful nor itchy. Rash blanches with pressure; maculopapular lesions with lighter halo, different sizes. No vesicular lesions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Sinusitis, URI
Vorgeschichte
adenoidectomy and b/l myringotomy tubes
Andere Medikamente
None
Allergien
NKDA, NKA
Vorherige Impfungen
-

VAERS 2223589

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

mild
Staat
MI
Alter
4,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
30.03.2022
Beginn
31.03.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site vesicles

Symptomtext

Pt developed pain and erythema in the Right leg. Mother called to report on 6 days after administration. Pictures that mother provided showed 3-4 vesicles around the injection site. Pt came to the office the day after mother contacted us and the vesicles had crusted over less than 24 hours after the picture. Per Mother patient reported pain in both legs starting the day after she received vaccinations, to the point it was difficult to put on pants, for over a week.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 2201708

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

mild
Staat
MA
Alter
12,0
Geschlecht
M
Eingang
28.03.2022
Impfdatum
28.03.2022
Beginn
28.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain upper Dizziness Nausea

Symptomtext

Student felt dizzy, nauseas and complained of stomach pain. After 15 minutes of observation, water, and cold pack to forehead, student felt better. Instructed to parent if symptoms return or worsen to seek medical attention.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain upper
Hospital-Tage
-
Labordaten
BP 110/70.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
None Reported
Andere Medikamente
Unknown
Allergien
No allergies reported
Vorherige Impfungen
-

VAERS 2166254

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

mild
Staat
-
Alter
16,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
08.03.2022
Beginn
08.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Malaise Pain Pallor

Symptomtext

Episode began 6:42pm, patient was given vaccine (MMR, varicella and PPD implant) and was getting ready to leave when he expressed to the RN that he was not feeling well. Patient then became pain and sat down. Automatic BP was attained and was 51/29, HR 51. RN notified PCP. Patient became pale and sweating, slow to respond Automatic BP was 46/29, manual BP was not detectable Patient was instructed to lay down and elevated the legs. Provider and PCP entered the room to assess patient. Pulse ox was recorded and patient was 100% At 6:51pm patient manual BP was 70/40, patient still diaphoretic and slow to respond but could answer questions intelligibly Patient denied swelling of the face, throat or SOB Another manual was obtained at 82/40, HR was 50bpm. Patient legs were elevated, and pulse ox remains 99% Random BS was obtained and was 68 at 6:55pm Another automatic and manual BP was obtained and was 90/52 Automatic BP was 91/56 at 7pm Another automatic BP was obtained 100/64, head of bed was then slightly elevated Patient stated that he was feeling better, and patient appeared less pale, Patient continued to denied SOB, difficulty breathing, itchiness or swelling in mouth or throat. Patient is response and able to respond to questions appropriately. Another automatic BP obtained: 99/62, HR 63. Another BP was obtained while patient sitting up straight, feet elevated: 96/60, HR 66. Pulse ox 100% Another BP obtained while sitting with feet elevated: 92/61 Patient endorsed that he is not feeling odd, no dizziness or no strange sensations noted. Another BP obtained with feet elevated: 98/59, HR 64 Another BP obtained with feet downwards: 105/70, HR 58 Another BP obtained with patient standing: 103/72, HR 68 Last BP was obtained with patient standing: 94/62, HR 85. Another BP at 7:30pm with patient sitting: 95/55, HR 85 Another BP at 7:30pm with patient standing: 96/66, HR 85 Another BP at 7:34pm with patient standing: 103/65, HR 85 Mom reports when he does not eat for along period of time; Pt. faints

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2679033

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
04.09.2023
Impfdatum
31.08.2023
Beginn
31.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE/PQC; HCP called to report inadvertent administration of expired VARIVAX to a patient; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. Concomitant therapies were not reported. On 31-AUG-2023, the patient was vaccinated inadvertent with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, at a dose of 0.5 milliliters, once (lot #U026207, with an expiration date on 24-AUG-2023), administered for prophylaxis (strength, and route of administration were not provided). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2678289

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
31.08.2023
Impfdatum
31.08.2023
Beginn
31.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Patient was administered an expired vaccine. Vaccine expired on 8/24/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2563922

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
20.01.2023
Impfdatum
05.01.2023
Beginn
05.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No adverse event; Nurse Aid called in to report a temperature excursion for VARIVAX where one dose was administered on 01/05/2023; This spontaneous report has been received from a Nurse aid, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant medications were not reported. On 05-JAN-2023, the patient was vaccinated with an improperly storage dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, 0.5 milliliters once as prophylaxis (lot number: U026207, which was determined to be valid, with an expiration date on 24-AUG-2023) (product storage error). The administered dose underwent a temperature excursion of 5.7 degrees Fahrenheit (F) for 9 minutes. It was reported that there was no any previous temperature excursion. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2469840

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge u026207

gering
Staat
WA
Alter
11,0
Geschlecht
M
Eingang
05.10.2022
Impfdatum
23.09.2022
Beginn
23.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Varifax given in error. No adverse effects known. The correct vaccine (gardasil) was also given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
none known
Vorherige Impfungen
-

VAERS 2439309

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
ME
Alter
1,2
Geschlecht
F
Eingang
10.09.2022
Impfdatum
10.08.2022
Beginn
10.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; a dose of VARIVAX was administered to the patient on 10AUG2022 after experiencing a temperautre excursion; This spontaneous report was received from a medical assistant referring to a 14-month-old female patient. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 10-AUG-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL, subcutaneously (lot # U026207, expiration date: 24-AUG-2023; strength, and anatomical location were not provided) for prophylaxis. It was reported that the suspect vaccine was underwent temperature excursions of 18.6 Fahrenheit (F) for 30 minutes (product storage error). The previous temperature excursion as follow: 9.8 F for 30 minutes. No additional adverse event (AE) was reported (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2208USA005443: US-009507513-2208USA005325: US-009507513-2208USA005272: US-009507513-2208USA005345: US-009507513-2208USA004819:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2412969

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
17.08.2022
Impfdatum
-
Beginn
25.07.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs; Caller reported VARIVAX was administered after temperature excursion.; This spontaneous report was received from a physician via office manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 25-JUL-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5ml subcutaneously, lot # U026207, expiration date 24-AUG-2023, for prophylaxis. The vaccine had been improperly stored in the temperature of 41.5 Fahrenheit degrees (F) for 2 hours and 45 minutes with no previous temperature excursion. It was unknown if digital data logger was involved. No adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2411946

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
ME
Alter
-
Geschlecht
U
Eingang
16.08.2022
Impfdatum
10.08.2022
Beginn
10.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no adverse event; a dose of VARIVAX was administered to the patient on 10AUG2022 after experiencing a temperautre excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 10-AUG-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot #U026207, expiration date: 24-AUG-2023 (strength, dosage regimen, anatomical location, and route of administration were not provided) as prophylaxis. It was reported that the vaccine underwent a temperature excursion of 18.6 Fahrenheit degrees for 30 minutes, with a previous temperature excursion of 9.8 Fahrenheit degrees for 30 minutes (product storage error). No adverse event was reported. This is one of several cases reported by the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2409340

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
IN
Alter
1,0
Geschlecht
M
Eingang
12.08.2022
Impfdatum
13.07.2022
Beginn
13.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no adverse event; received VARIVAX/that experienced a temperature excursion; This spontaneous report was received from a registered nurse referring to unknown patients of unknown age and gender. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 11-JUL-2022, following vaccines were administered after temperature excursion to 10.8 degree Celsius for 2 hours 27 minutes (product storage error). Names of vaccines involved: measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) (lot # U011995, expiration date: 15-APR-2023, lot # U009511 expiration date: 25-MAR-2023, lot# U014656 expiration date: 07-MAY-2023, lot # U022318, expiration date: 15-JUL-2023, lot # T025930, expiration date: 30-JUL-2022, lot # U029619, expiration date: 22-SEP-2023) for prophylaxis (strength, dose and route of administration were not provided), measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) (lot #U029319, expiration date: 19-MAR-2023, lot# U024296 expiration date 21-SEP-2023, lot# U039723 expiration date: 15-DEC-2023, lot# U015679 expiration 18-AMY-2023), varicella virus vaccine live (oka/merck) (VARIVAX) (lot #U010396, expiration date: 01-APR-2023, lot# U039723 expiration date: 15-DEC-2023, lot# U015679 expiration date: 18-MAY-2023, U024296 is an invalid lot number for varicella virus vaccine live (oka/merck) (VARIVAX) expiration date reported as 21-SEP-2023) for prophylaxis (all vaccines strength, dose, anatomical location and route of administration were not provided). The reported was unsure how many administrations occurred and did not have individual patient information. No additional adverse event was reported (no adverse event). This case is non-valid due to the number of patients was unspecified and lack of patients' identifiers. Follow-up information was received from a registered nurse on 09-AUG-2022. This case was previously considered non-valid but per follow-up it was determined to be valid (there were only 3 patients who receive the vaccines). This spontaneous report refers to a 12 month old male patient. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 13-JUL-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # U026207, expiration date 24-AUG-2023, for prophylaxis (dose and route of administration was not provided) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot # U009511, expiration date 25-MAR-2023 (dose and route of administration was not provided) for prophylaxis, both experienced a temperature excursion. No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2207USA005428: US-009507513-2208USA004875:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2397918

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
-
Alter
1,8
Geschlecht
F
Eingang
01.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration

Symptomtext

Administered IM instead of SC

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2396479

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
IA
Alter
1,0
Geschlecht
F
Eingang
29.07.2022
Impfdatum
20.06.2022
Beginn
20.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

No Adverse Events noted. Patients PCP was notified Attempted to call patients mom -Left a message to return our call.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2374985

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u026207

gering
Staat
-
Alter
8,0
Geschlecht
F
Eingang
20.07.2022
Impfdatum
10.06.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration

Symptomtext

Interval not met with live vaccines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2374982

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u026207

gering
Staat
-
Alter
9,0
Geschlecht
F
Eingang
20.07.2022
Impfdatum
10.06.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration

Symptomtext

Interval not met with live vaccines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2374980

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u026207

gering
Staat
-
Alter
5,0
Geschlecht
F
Eingang
20.07.2022
Impfdatum
01.06.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Interval not met with live vaccines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2334816

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
IA
Alter
1,3
Geschlecht
F
Eingang
25.06.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Wrong product administered

Symptomtext

a 15 month old child received PROQUAD and VARIVAX on the same day. The patient was supposed to get MMRII but received PROQUAD instead due to human error; a 15 month old child received PROQUAD and VARIVAX on the same day. The patient was supposed to get MMRII but received PROQUAD instead due to human error; No additional AEs were reported; This spontaneous report was received from a medical assistant and refers to a 15-month-old female patient. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On an unknown date, the 15-month-old child patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5ml, once, lot #:U031564, expiration date: 06-APR-2023; and a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5ml,once, lot #: U026207, expiration date: 24-AUG-2023 (strengths, sites and routes of administration were not provided) for prophylaxis. The patient was supposed to get a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (exact dose, strength, lot #, expiration date, site and route of administration, albumin status were not provided) but received measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) instead due to human error (wrong product administered; extra dose administered). There was no additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2315934

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u026207

gering
Staat
CA
Alter
30,0
Geschlecht
M
Eingang
10.06.2022
Impfdatum
27.05.2022
Beginn
27.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site bruising

Symptomtext

pt developed bruise where vaccination was given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2301733

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
30.05.2022
Impfdatum
28.04.2022
Beginn
28.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

the vaccine was administered after temperature excursion; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medications, concurrent conditions, medical history and drug reactions/allergies were not reported. On 28-APR-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (strength, dose, route were not reported, lot # U026207, expiration date 24-AUG-2023 or lot # U029496, expiration date 21-SEP-2023, it was unknown which lot was administered) for prophylaxis after temperature excursion (product storage error). The vaccine was exposed to temperature at minus 9 degrees Celsius for 1 hour and 45 minutes. There was no previous temperature excursion. No additional information.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2293864

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
25.05.2022
Impfdatum
-
Beginn
27.04.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Varivax administered after temperature excursion; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 27-APR-2022, the patient received inappropriately stored (product storage error) live (oka/merck) (VARIVAX) with lot number U026207 and expiration date 24-AUG-2023 or with lot number U029496 and expiration date 21-SEP-2023 (route of administration and anatomical location were not reported). The temperature excursion was at a temperature of -9 degree Celsius for a timeframe of 1 hour and 45 minutes, without previous excursions. No PQC (product quality complaint) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2205USA006728: US-009507513-2205USA006727: US-009507513-2205USA006726: US-009507513-2205USA006725: US-009507513-2205USA006729: US-009507513-2205USA006724:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2254685

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
17.05.2022
Impfdatum
26.04.2022
Beginn
26.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

No additional AE; Medical assistant reported that a patient received additional VARIVAX.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age or gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was properly vaccinated with measles, mumps, and rubella (WISTAR RA 27-3) virus vaccine, live (MMR II) (strength, dose, route of administration, lot # and expired date were not provided) and varicella virus vaccine live (OKA/MERCK) (VARIVAX) (strength, dose, route of administration, lot # and expired date were not provided); however on 26-APR-2022, the patient received another dose of varicella virus vaccine live (OKA/MERCK) (VARIVAX) (Extra dose administered) (valid lot #U026207, expiration date: 24-AUG-2023) for prophylaxis (strength and route of administration were not provided) which was reconstituted with a sterile diluent (valid lot #T015779, expiration date: 02-DEC-2022). No additional adverse events were reported, no further information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2241161

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
OH
Alter
15,0
Geschlecht
M
Eingang
14.05.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event Wrong product administered Extra dose administered

Symptomtext

No additional AE reported.; HCP reported that a patient received a dose of PROQUAD and VARIVAX accidently instead of MMR II and VARIVAX.; HCP reported that a patient received a dose of PROQUAD and VARIVAX accidently instead of MMR II and VARIVAX.; This spontaneous report has been received from the nurse prescriber concerning a 15-year-old male patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 19-APR-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human Albumin (rHA) (PROQUAD), lot #U039262 with expiration date 09-JUN-2023 (dose description, route of administration, anatomical location were not provided) as prophylaxis; and with a dose of varicella virus vaccine live (oka/merck) (VARIVAX), lot #U026207, with expiration date 24-AUG-2023 (dose description, route of administration, anatomical location were not provided), as prophylaxis (Accidental overdose), instead of receive the vaccine scheme dose with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (strength, dose, lot #, expiry date, route of administration, anatomical location were not provided), as prophylaxis and varicella virus vaccine live (VARIVAX) (wrong vaccine administered). No additional adverse event (AE) or PQC reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2270500

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
11.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Inbound call from nurse to complete temperature excursion for VARIVAX. Complete excursion details collected from nurse, it was reported that the vaccine was administered after temperature excursion. No PQC. No additional information. ? N; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported. On 29-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U026207, expiration date 24-AUG-2023 and lot number U029496, expiration date 21-SEP-2023) as prophylaxis, after temperature excursion (product storage error). The vaccines experienced a temperature excursion of minus (-) 9 degrees Celsius (C) for 1 hour and 45 minutes. There was no previous temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2270498

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
11.05.2022
Impfdatum
27.04.2022
Beginn
27.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Inbound call from nurse to complete temperature excursion for VARIVAX. Complete excursion details collected from nurse, it was reported that the vaccine was administered after temperature excursion. No PQC. No additional information. ? N; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported. On 27-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U026207, expiration date 24-AUG-2023 and lot number U029496, expiration date 21-SEP-2023) as prophylaxis, after temperature excursion (product storage error). The vaccine experienced a temperature excursion of minus 9 degrees Celsius (C) for 1 hour and 45 minutes. There was no previous temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265567

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
06.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

the vaccine was administered after temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies was provided. On 29-APR-2022, the patient was vaccinated with an improperly stored dose (administered after temperature excursion) of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U026207 with expiration date of 24-AUG-2023 or lot # U029496 with expiration date of 21-SEP-2023, for prophylaxis (dose, route of administration and frequency were not reported). Temperature excursion -9 C; Time frame 1 hour 45 minutes; no previous temperature excursion. No further information provide. ?

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2264216

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
05.05.2022
Impfdatum
28.04.2022
Beginn
28.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

the vaccine was administered after temperature excursion.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies was provided. On 28-APR-2022, the patient was vaccinated with an improperly stored dose (administered after temperature excursion) of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U026207 with expiration date of 24-AUG-2023 or lot # U029496 with expiration date of 21-SEP-2023, for prophylaxis (dose, route of administration and frequency were not reported). Temperature excursion -9 C; Time frame 1 hour 45 minutes; no previous temperature excursion. No further information provide.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2264215

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
05.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

the vaccine was administered after temperature excursion.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies was provided. On 29-APR-2022, the patient was vaccinated with an improperly stored dose (administered after temperature excursion) of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U026207 with expiration date of 24-AUG-2023 or lot # U029496 21-SEP-2023, for prophylaxis (dose, route of administration and frequency were not reported). Temperature excursion -9 C; Time frame 1 hour 45 minutes; no temperature excursion No further information provide.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2220322

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U026207

gering
Staat
NY
Alter
0,9
Geschlecht
M
Eingang
07.04.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient given vaccine before their first birthday (12 months). No s/s of adverse reaction at the time. No treatment was given, assessed by MD, MD stated will follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-